Eike Steidl

875 total citations
21 papers, 156 citations indexed

About

Eike Steidl is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eike Steidl has authored 21 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eike Steidl's work include Glioma Diagnosis and Treatment (14 papers), Advanced MRI Techniques and Applications (5 papers) and MRI in cancer diagnosis (4 papers). Eike Steidl is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Advanced MRI Techniques and Applications (5 papers) and MRI in cancer diagnosis (4 papers). Eike Steidl collaborates with scholars based in Germany, United States and Netherlands. Eike Steidl's co-authors include Elke Hattingen, Joachim P. Steinbach, Katharina Filipski, Michael Ronellenfitsch, Gabriele D. Maurer, Oliver Bähr, Patrick N. Harter, Philipp Lohmann, Nenad Polomac and N. Jon Shah and has published in prestigious journals such as Immunity, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Eike Steidl

19 papers receiving 155 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eike Steidl Germany 7 107 83 24 23 20 21 156
Jochen Tüttenberg Germany 7 95 0.9× 86 1.0× 17 0.7× 27 1.2× 21 1.1× 9 187
Alice Métais France 8 91 0.9× 29 0.3× 22 0.9× 33 1.4× 38 1.9× 29 150
Inés Domínguez‐Prado Spain 10 35 0.3× 257 3.1× 21 0.9× 51 2.2× 17 0.8× 18 317
Daniel Delev Germany 9 60 0.6× 41 0.5× 17 0.7× 8 0.3× 27 1.4× 13 377
Elena V. Daoud United States 7 77 0.7× 22 0.3× 19 0.8× 24 1.0× 38 1.9× 17 148
Tristan Penson United States 4 102 1.0× 62 0.7× 26 1.1× 55 2.4× 20 1.0× 5 198
Raquel Sevilla United States 6 33 0.3× 27 0.3× 25 1.0× 18 0.8× 7 0.3× 10 123
Ema Yoshioka Japan 7 111 1.0× 52 0.6× 38 1.6× 28 1.2× 21 1.1× 12 146
Lucia Nichelli France 7 71 0.7× 55 0.7× 5 0.2× 24 1.0× 40 2.0× 38 147
Yosuke Kitagawa Japan 7 74 0.7× 51 0.6× 19 0.8× 30 1.3× 12 0.6× 19 142

Countries citing papers authored by Eike Steidl

Since Specialization
Citations

This map shows the geographic impact of Eike Steidl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eike Steidl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eike Steidl more than expected).

Fields of papers citing papers by Eike Steidl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eike Steidl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eike Steidl. The network helps show where Eike Steidl may publish in the future.

Co-authorship network of co-authors of Eike Steidl

This figure shows the co-authorship network connecting the top 25 collaborators of Eike Steidl. A scholar is included among the top collaborators of Eike Steidl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eike Steidl. Eike Steidl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lun, Jennifer H., Aakanksha Singh, Jadranka Macas, et al.. (2025). Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. Immunity. 58(11). 2847–2863.e8. 1 indexed citations
2.
Steidl, Eike, Manoj Shrestha, Ralf Deichmann, et al.. (2024). Pathological tissue changes in brain tumors affect the pH‐sensitivity of the T1‐corrected apparent exchange dependent relaxation (AREX) of the amide protons. NMR in Biomedicine. 38(1). e5285–e5285. 1 indexed citations
3.
Steidl, Eike, Katharina Filipski, Elke Hattingen, Joachim P. Steinbach, & Gabriele D. Maurer. (2023). Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and progressive glioblastoma. PLoS ONE. 18(2). e0274400–e0274400. 1 indexed citations
4.
Rauch, Maximilian, Fee Keil, Eike Steidl, et al.. (2022). Topographic Mapping of Isolated Thalamic Infarcts Using Vascular and Novel Probabilistic Functional Thalamic Landmarks. Clinical Neuroradiology. 33(2). 435–444.
5.
Urban, Hans, Eike Steidl, Elke Hattingen, et al.. (2022). Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization. Frontiers in Immunology. 12. 798811–798811. 13 indexed citations
6.
Foerch, Christian, Joachim P. Steinbach, Elke Hattingen, et al.. (2022). The Acute Superficial Siderosis Syndrome — Clinical Entity, Imaging Findings, and Histopathology. The Cerebellum. 22(2). 296–304. 5 indexed citations
7.
Müller, Marguerite, Oliver Winz, Ralph T. H. Leijenaar, et al.. (2022). Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression. Journal of Neuro-Oncology. 159(3). 519–529. 15 indexed citations
8.
9.
Steidl, Eike, Maximilian Rauch, Elke Hattingen, et al.. (2022). Qualitative and quantitative detectability of hypertrophic olivary degeneration in T2, FLAIR, PD, and DTI: A prospective MRI study. Frontiers in Neurology. 13. 950191–950191. 3 indexed citations
10.
Hattingen, Elke, Eike Steidl, Felix Rosenow, et al.. (2021). Heterotopia in Individuals with 22q11.2 Deletion Syndrome. American Journal of Neuroradiology. 42(11). 2070–2076. 3 indexed citations
11.
Schaller, Martin, Eike Steidl, Manoj Shrestha, et al.. (2021). Multicenter Prospective Analysis of Hypertrophic Olivary Degeneration Following Infratentorial Stroke (HOD-IS): Evaluation of Disease Epidemiology, Clinical Presentation, and MR-Imaging Aspects. Frontiers in Neurology. 12. 675123–675123. 8 indexed citations
12.
Steidl, Eike, Katharina Filipski, Pia S. Zeiner, et al.. (2021). A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy. Journal of Cancer Research and Clinical Oncology. 147(8). 2373–2383. 3 indexed citations
13.
Steidl, Eike, Marlies Wagner, Katharina Filipski, et al.. (2021). Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas. Oncology. 99(4). 215–224. 1 indexed citations
14.
Schaller, Martin, Peter Baumgarten, Volker Seifert, et al.. (2021). A Paravermal Trans-Cerebellar Approach to the Posterior Fossa Tumor Causes Hypertrophic Olivary Degeneration by Dentate Nucleus Injury. Cancers. 13(2). 258–258. 6 indexed citations
15.
Steidl, Eike, Karl‐Josef Langen, Nenad Polomac, et al.. (2020). Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 1956–1965. 36 indexed citations
16.
Voß, Martin, Eike Steidl, Marlies Wagner, et al.. (2019). Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab. Journal of Clinical Medicine. 8(10). 1608–1608. 2 indexed citations
17.
Steidl, Eike, Mathias Müller, Andreas Müller, Ulrich Herrlinger, & Elke Hattingen. (2019). Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study. Journal of Neuro-Oncology. 144(2). 409–417. 7 indexed citations
18.
Steidl, Eike, et al.. (2019). Early diagnosis in a case of atypically located germinoma: 1H-MR-spectroscopy as a decision tool. Oxford Medical Case Reports. 2019(2). omz001–omz001. 2 indexed citations
19.
Zeiner, Pia S., Martina Kinzig, Gabriele D. Maurer, et al.. (2019). Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients. Journal of Clinical Medicine. 8(12). 2031–2031. 24 indexed citations
20.
Steidl, Eike, Ulrich Pilatus, Elke Hattingen, et al.. (2016). Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. PLoS ONE. 11(12). e0168113–e0168113. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochen Tüttenberg Breakdown of academic impact, for papers by Alice Métais Breakdown of academic impact, for papers by Inés Domínguez‐Prado Breakdown of academic impact, for papers by Daniel Delev Breakdown of academic impact, for papers by Elena V. Daoud Breakdown of academic impact, for papers by Tristan Penson Breakdown of academic impact, for papers by Raquel Sevilla Breakdown of academic impact, for papers by Ema Yoshioka Breakdown of academic impact, for papers by Lucia Nichelli Breakdown of academic impact, for papers by Yosuke Kitagawa
Rankless by CCL
2026